uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 20, 2010

Many Supplements Recalled for Hormone-Affecting Compounds

On September 20, 2010, the U.S. FDA posted a Safety Notice regarding the recalls of several products marketed as dietary supplements that contain aromatase inhibitors, commonly known as "ATD." Adverse events associated with the use of aromatase inhibitors could include the following: decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure, and liver dysfunction. Consumers with liver, kidney, adrenal, or prostate abnormalities are at higher risk for developing adverse events.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at